| Patient | Pierre Le Moyne d'Iberville |
|---|---|
| Date of birth | 1661-07-16 |
| Identifiers | MRN HR-ET014-SYN-TD; SSN (made up) 000-14-7260 |
| Document date | 1705-02-17 |
| Author | Marguerite Delacroix-Boateng, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Three episodes of fever with shaking chills and sweats in two years, each beginning months after naval service in malaria-endemic areas, the first called malaria abroad and treated with chloroquine alone, in a 43-year-old naval commander who is afebrile today. Please establish whether these are malaria relapses, advise on antirelapse treatment, and plan his pre-travel care for a deployment to French Guiana and the French Antilles expected early next year. [S]
Urgency: Within two weeks; same day if he develops a fever. [S]
Questions for the consultant:
Three febrile attacks in two years, each lasting about a week with chills every other day, drenching sweats and headache; the first diagnosed abroad as malaria on a smear, species not recorded, and treated with chloroquine alone; the later two treated with chloroquine without testing; the last ended six weeks ago. Earlier service on the Caribbean coast of Central America and in the Gulf of Mexico. No other illness, no regular medicines, no allergies. Afebrile today; temperature 36.7 C, blood pressure 124/78, pulse 70; spleen not palpable. Thick and thin smears and the rapid antigen test today are negative; Plasmodium species PCR sent to the reference laboratory. Hemoglobin 13.0 g/dL, platelets 141 x10^3/uL, white cells 5.6 x10^3/uL, bilirubin 1.1 mg/dL, ALT 34 U/L, AST 29 U/L, creatinine 0.98 mg/dL (eGFR 98), glucose 92 mg/dL. Quantitative G6PD activity 11.8 U/g Hb, normal. He expects to command a deployment to French Guiana and the French Antilles early next year, with months ashore and possible inland river work, and fears an attack at sea [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
3 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Recurrent episodes of fever with shaking chills and drenching sweats, three in the past two years, each beginning months after naval service in malaria-endemic areas; the first diagnosed as malaria abroad on a blood smear with the species not recorded and treated with chloroquine alone, the later two treated with chloroquine without testing; the last ended six weeks before intake; afebrile and well at intake; cause not established at intake; infectious diseases consultation requested | active | confirmed | R50.9 | S — Synthetic presenting problem anchored to his documented recurrent attacks of illness called malaria; superseded by the diagnosis at the infectious diseases consultation. |
| Pre-travel care for a naval deployment, expected to sail early next year, to French Guiana and the French Antilles: yellow fever vaccination required for entry to French Guiana, malaria prevention, dengue, chikungunya and typhus prevention by vector avoidance, food and water safety, and travel vaccines | active | confirmed | Z71.84 | S — Synthetic modern counterpart of his documented preparation of a tropical campaign in 1705. |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| late 1701 | An illness at sea, nature not recorded, that forced him to put in at port on a voyage to the Gulf of Mexico about three and a half years before intake | D (CLM-0007) |
| 1702 onward | Recurrent attacks of illness over the past three years, described by his biographer as malaria, that kept him from planned voyages | D (CLM-0008) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1705-02-17 | Body height | 175 | cm | S |
| 1705-02-17 | Body weight | 68.4 | kg | S |
| 1705-02-17 | Body mass index (BMI) [Ratio] | 22.3 | kg/m2 | S |
| 1705-02-17 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1705-02-17 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1705-02-17 | Heart rate | 70 | /min | S |
| 1705-02-17 | Respiratory rate | 14 | /min | S |
| 1705-02-17 | Body temperature | 36.7 | Cel | S |
| 1705-02-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1705-02-17 | Hemoglobin [Mass/volume] in Blood | 13 | g/dL | 13.2-17.1 g/dL | Low | S |
| 1705-02-17 | Leukocytes [#/volume] in Blood by Automated count | 5.6 | 10*3/uL | 3.4-9.6 10*3/uL | Normal | S |
| 1705-02-17 | Platelets [#/volume] in Blood by Automated count | 141 | 10*3/uL | 150-400 10*3/uL | Low | S |
| 1705-02-17 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 136-145 mmol/L | Normal | S |
| 1705-02-17 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1705-02-17 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1705-02-17 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 1705-02-17 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 34 | U/L | 7-52 U/L | Normal | S |
| 1705-02-17 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 29 | U/L | 13-39 U/L | Normal | S |
| 1705-02-17 | Bilirubin.total [Mass/volume] in Serum or Plasma | 1.1 | mg/dL | 0.3-1.2 mg/dL | Normal | S |
| 1705-02-17 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells | 11.8 | U/g{Hb} | 7-20.5 U/g{Hb} | Normal | S |
| 1705-02-17 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1700)/1.73 sq M | 98 | mL/min/{1.73_m2} | 60 or more | Normal | S |